Vimarsana
Biggest News Aggregation in the World

Page 4 - Confidence Intervals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Confidence Intervals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Confidence Intervals Today - Breaking & Trending Today

UGA research provides insight into flood trends - Vimarsana News

UGA research provides insight into flood trends

New research released from The University of Georgia has recently provided a pathway to achieving a more simplified and cost-effective method for flood mapping that can account for the rising

High REM AHI & Hypertension in Females with OSA - Vimarsana News

High REM AHI & Hypertension in Females with OSA

The clinical & polysomnographic characteristics of OSA patients with hypertension, & the gender differences in the relationship between REM OSA & hypertension.

Chronic Viral Hepatitis in Kazakhstan - Vimarsana News

Chronic Viral Hepatitis in Kazakhstan

The aim of the study was to perform an estimation of mortality, prevalence and incidence of Hepatitis B and C infections and liver-related complications.

Exposure to different types of mass media and timing of antenatal care initiation: insights from the 2016 Uganda Demographic and Health Survey | BMC Women's Health - Vimarsana News

Exposure to different types of mass media and timing of antenatal care initiation: insights from the 2016 Uganda Demographic and Health Survey | BMC Women's Health

Early initiation of antenatal care (ANC) within the first trimester is highly recommended in the current 2016 World Health Organization (WHO) guidelines. Mass media has the potential to promote early initiation of ANC because it has been used successfully in several programs. However, there is paucity of literature on the effect of exposure to different types of media on the timing of ANC initiation in Uganda. Our study aimed at exploring associations between exposure to different types of mass media and timing of ANC initiation among women in Uganda. We used a cross sectional study design, to...

Samsung Bioepis' SB12 Soliris® (Eculizumab) Biosimilar - Vimarsana News

Samsung Bioepis' SB12 Soliris® (Eculizumab) Biosimilar

Phase 1 study demonstrated pharmacokinetics (PK) equivalence and comparable pharmacodynamic (PD), safety, immunogenicity profiles between SB12 and...